BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 30778553)

  • 1. Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression.
    Belmokhtar K; Ortillon J; Jaisson S; Massy ZA; Boulagnon Rombi C; Doué M; Maurice P; Fritz G; Gillery P; Schmidt AM; Rieu P; Touré F
    Nephrol Dial Transplant; 2019 Dec; 34(12):2018-2030. PubMed ID: 30778553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
    Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for Advanced Glycation End Products is Involved in Platelet Hyperactivation and Arterial Thrombosis during Chronic Kidney Disease.
    Ortillon J; Hézard N; Belmokhtar K; Kawecki C; Terryn C; Fritz G; Kauskot A; Schmidt AM; Rieu P; Nguyen P; Maurice P; Touré F
    Thromb Haemost; 2020 Sep; 120(9):1300-1312. PubMed ID: 32726852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TDAG51 (T-Cell Death-Associated Gene 51) Is a Key Modulator of Vascular Calcification and Osteogenic Transdifferentiation of Arterial Smooth Muscle Cells.
    Platko K; Lebeau PF; Gyulay G; Lhoták Š; MacDonald ME; Pacher G; Hyun Byun J; Boivin FJ; Igdoura SA; Cutz JC; Bridgewater D; Ingram AJ; Krepinsky JC; Austin RC
    Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1664-1679. PubMed ID: 32434409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apelin: A novel inhibitor of vascular calcification in chronic kidney disease.
    Han X; Wang LY; Diao ZL; Liu WH
    Atherosclerosis; 2016 Jan; 244():1-8. PubMed ID: 26581047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium Overload Accelerates Phosphate-Induced Vascular Calcification Via Pit-1, but not the Calcium-Sensing Receptor.
    Masumoto A; Sonou T; Ohya M; Yashiro M; Nakashima Y; Okuda K; Iwashita Y; Mima T; Negi S; Shigematsu T
    J Atheroscler Thromb; 2017 Jul; 24(7):716-724. PubMed ID: 27840385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.
    Choi SY; Ryu HM; Oh EJ; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    PLoS One; 2017; 12(7):e0180393. PubMed ID: 28686724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sitagliptin attenuates arterial calcification by downregulating oxidative stress-induced receptor for advanced glycation end products in LDLR knockout mice.
    Lin CP; Huang PH; Chen CY; Wu MY; Chen JS; Chen JW; Lin SJ
    Sci Rep; 2021 Sep; 11(1):17851. PubMed ID: 34497344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.
    Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J
    BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular calcification in skin and subcutaneous tissue in patients with chronic and end-stage kidney disease.
    Ruderman I; Hewitson TD; Smith ER; Holt SG; Wigg B; Toussaint ND
    BMC Nephrol; 2020 Jul; 21(1):279. PubMed ID: 32677907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner.
    Yan L; Mathew L; Chellan B; Gardner B; Earley J; Puri TS; Hofmann Bowman MA
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1399-411. PubMed ID: 24855059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperphosphatemia-induced degradation of transcription factor EB exacerbates vascular calcification.
    Ishiwata R; Morimoto Y
    Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166323. PubMed ID: 34921974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uremic serum-induced calcification of human aortic smooth muscle cells is a regulated process involving Klotho and RUNX2.
    Patidar A; Singh DK; Thakur S; Farrington K; Baydoun AR
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31519772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cells exposed to phosphate and indoxyl sulphate promote vascular calcification through interleukin-8 secretion.
    Bouabdallah J; Zibara K; Issa H; Lenglet G; Kchour G; Caus T; Six I; Choukroun G; Kamel S; Bennis Y
    Nephrol Dial Transplant; 2019 Jul; 34(7):1125-1134. PubMed ID: 30481303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress contributes to vascular calcification in patients with chronic kidney disease.
    Huang M; Zheng L; Xu H; Tang D; Lin L; Zhang J; Li C; Wang W; Yuan Q; Tao L; Ye Z
    J Mol Cell Cardiol; 2020 Jan; 138():256-268. PubMed ID: 31866376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SGK3 promotes vascular calcification via Pit-1 in chronic kidney disease.
    Dong QQ; Tu YC; Gao P; Liao QQ; Zhou P; Zhang H; Shu HP; Sun LL; Feng L; Yao LJ
    Theranostics; 2024; 14(2):861-878. PubMed ID: 38169564
    [No Abstract]   [Full Text] [Related]  

  • 19. The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis.
    Menini S; Iacobini C; Ricci C; Blasetti Fantauzzi C; Salvi L; Pesce CM; Relucenti M; Familiari G; Taurino M; Pugliese G
    Cardiovasc Res; 2013 Dec; 100(3):472-80. PubMed ID: 23975852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase D: A new mediator during high phosphate-induced vascular calcification associated with chronic kidney disease.
    Skafi N; Abdallah D; Soulage C; Reibel S; Vitale N; Hamade E; Faour W; Magne D; Badran B; Hussein N; Buchet R; Brizuela L; Mebarek S
    J Cell Physiol; 2019 Apr; 234(4):4825-4839. PubMed ID: 30207376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.